Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exendin-4 in obese adults with type 2 diabetes mellitus poorly controlled on metformin
ChiCTR-TNC-10000874Phase 4Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Jan 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: serum insulin, C-reactive protein and 4 more. Started Jan 2010; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TNC-10000874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000874.